J Clin Microbiol 2000 Oct;38(10):3879-81

Vancomycin-intermediate Staphylococcus aureus in Korea.

Kim MN, Pai CH, Woo JH, Ryu JS, Hiramatsu K.



Department of Clinical Pathology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. mnkim@www.amc.seoul.kr

Recent reports on some methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin have been a major concern in Korea because of the widespread use of vancomycin due to a high prevalence of MRSA in the country. We describe a 45-year-old man with long-standing pelvic abscess due to MRSA. In spite of vancomycin and teicoplanin treatment for a long period of time, the patient died from MRSA sepsis. The blood culture isolate of MRSA exhibited reduced susceptibility to vancomycin (MIC, 8 microg/ml). This is the first report of a vancomycin-intermediate S. aureus case from Korea.